FKBP12 in Tgf-Beta Type I Receptor Mediated Signaling

Wang, Tongwen

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of General Medical Sciences (NIGMS)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29GM053710-02
• Application #: 2193109
• Study Section: Cellular Biology and Physiology Subcommittee 1 (CBY)
• Project Start: 1995-09-30
• Project End: 2000-08-31
• Budget Start: 1996-09-01
• Budget End: 1997-08-31
• Support Year: 2
• Fiscal Year: 1996

Institution

• Name: Massachusetts General Hospital
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02199

Publications

Liu, X; Elia, A E; Law, S F et al. (2000) A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1. EMBO J 19:6759-69

Wang, T; Li, B Y; Danielson, P D et al. (1996) The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell 86:435-44